Amrutanjan Health Care Ltd - AMRUTANJAN HEALT Share Price

Sector: Pharmaceuticals | ISIN: INE098F01031
₹ 662.45 (-1.08%) icon23 Feb, 2024, 12:00:00 AM

Amrutanjan Health Care Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 2/23/2024 12:00:00 AM

    ₹ 662.45 -7.20 -1.08
  • Open
  • ₹ 671
  • Prev. Close
  • ₹ 669.65
  • Turnover(Lac.)
  • ₹ 377
  • Day's High
  • ₹ 674.85
  • Day's Low
  • ₹ 657.2
  • 52 Week's High
  • ₹ 775.45
  • 52 Week's Low
  • ₹ 554.05
  • Book Value
  • ₹ 110.19
  • Face Value
  • ₹ 1
  • Mkt Cap (₹ Cr.)
  • 1,936.38
  • P/E
  • 44.03
  • EPS
  • 15.06
  • Divi. Yield
  • 0.69

Amrutanjan Health Care Ltd Corporate Actions

09 Feb , 2024

12:00 AM

Dividend

Dividend amount: 1
Announcement date: 09 Feb , 2024

View Details

01 Feb , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Feb , 2024

12:00 AM

10 Nov , 2023

12:00 AM

Dividend

Dividend amount: 1
Announcement date: 10 Nov , 2023

View Details

02 Nov , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Nov , 2023

12:00 AM

02 Aug , 2023

12:00 AM

AGM

Announcement date: 02 Aug , 2023

View Details

30 May , 2023

12:00 AM

Dividend

Dividend amount: 2.6
Announcement date: 30 May , 2023

View Details

26 Jul , 2023

12:00 AM

26 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

26 Jun , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

19 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Aug , 2023

12:00 AM

BookCloser

View Details

Amrutanjan Health Care Ltd News and Update

Image not found
  • 23 February, 2024 |
  • 12:07 AM

Under the "ILS Hospitals" brand, GPT Healthcare Ltd. manages a network of mid-sized full-service hospitals that offer integrated healthcare services, with an emphasis on secondary and tertiary care.

Image not found
  • IIFL News Service |
  • 22 February, 2024 |
  • 12:06 AM
Image not found
  • IIFL News Service |
  • 22 February, 2024 |
  • 12:06 AM
Image not found
  • IIFL News Service |
  • 16 February, 2024 |
  • 11:57 PM

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Amrutanjan Health Care Ltd SHAREHOLDING SNAPSHOT
26 February , 2024 | 12:59 AM

PROMOTER - TOTAL50.59%

Indian: 50.59%

Foreign: 0%

NON-PROMOTER - TOTAL 49.23%

Institutions: 8.04%

Non-Institutions: 41.19%

CUSTODIES - 0.18%

Custodies: 0.18%

See More Details
ad IconAd Image

Amrutanjan Health Care Ltd FINANCIALS

Amrutanjan Health Care Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Amrutanjan Health Care Ltd

  • S Sambhuprasad
  • CMD & Executive Director
  • Marie Shiranee Pereira
  • Independent Non Exe. Director
  • V Raja
  • Independent Non Exe. Director
  • Muralidharan Swayambunathan
  • Independent Non Exe. Director
  • Meena Lochani Raghunathan
  • Independent Non Exe. Director
  • Ramaa Prabhakar Arikirevula
  • Non Executive Director
  • M Srinivasan.
  • Company Sec. & Compli. Officer

Summary

Amrutanjan Health Care Limited (AHCL) was incorporated on September 9, 1936 in Chennai, Tamil Nadu. The Chennai-based Amrutanjan manufactures bulk drugs and drug intermediates like theophylline, based on in-house research. Three plants have been set up in the Alandur industrial belt near Chennai to produce these products. It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore. Pheromones have found wide application as pesticides and are used on cotton crops. The Company is engaged into manufacture, supply, sale of products in pain management, congestion management, beverages & hygiene and services in pain management.Amrutanjan has an agreement with a company in Philadelphia, US, to supply custom-made chemicals for exotic applications like the genetic manipulation of biological matter. It has introduced some new range of products like Pep Pill, Amrutanjan gripe water sans alcohol, Amrutanjan Maha Strong, etc. Plans are afoot to introduce analgesic and antipyretic tablets. The company also plans to launch sanitary napkins soon. The company has approached the US FDA for approval and clearance to sell its new drugs in US. During 1996-97, it has introduced a new product called Cold Snap Gel and also a mint called tingle. Company having two subsidiary companies viz. Amrutanjan Drugs & Chemicals Ltd having holding stake 99.80% & Amrutanjan Finance Ltd, having holding stake is 57.26%.Company has... Read More


Reports by Amrutanjan Health Care Ltd


Reports by Amrutanjan Health Care Ltd

Company FAQ

No Record Found